One leading prostate cancer specialist cast serious doubt yesterday on the wisdom of predicting that Megrahi had only three months to live – when a patient still had to undergo chemotherapy. Dr Chris Parker said it was extremely difficult to give an accurate prognosis for individual patients. "Studies show experts are very poor at trying to predict how long an individual patient will live for," he warned.